| ²é¿´: 838 | »Ø¸´: 4 | ||
ÖñÁÖØüÈ»Ìú³æ (СÓÐÃûÆø)
|
[ÇóÖú]
Ö±³¦°©Í¬²½·Å»¯ÁÆÊ±FOL-FOX4¼ÁÁ¿
|
| ÇóÖúÖ±³¦°©Í¬²½·Å»¯ÁÆÊ±FOL-FOX4¼ÁÁ¿Ïà¹ØµÄÎÄÏ×»ò×ÊÁÏ£¨½ÏÐµģ©£¬Ê®·Ö¸Ðл£¡ |
» ²ÂÄãϲ»¶
Ô¤·ÀҽѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ76È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
°¢Ë¾Æ¥ÁֿɽµµÍ½áÖ±³¦°©·¢²¡ÂÊ
ÒѾÓÐ7È˻ظ´
Çë°ïæ·ÖÎöÖ±³¦°©²¡Çé¼°ºó¼ÌÖÎÁÆ·½°¸
ÒѾÓÐ7È˻ظ´
ÇóÖú£ºÓ¢Ò뺺4¾ä»°£¬²»Ê¤¸Ð¼¤
ÒѾÓÐ2È˻ظ´
cancerguy
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 279
- Ìû×Ó: 22
- ÔÚÏß: 5Сʱ
- ³æºÅ: 1484906
- ×¢²á: 2011-11-10
- ÐÔ±ð: GG
- רҵ: Ïû»¯ÏµÍ³Ö×Áö
2Â¥2011-11-11 22:56:31
cancerguy
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 279
- Ìû×Ó: 22
- ÔÚÏß: 5Сʱ
- ³æºÅ: 1484906
- ×¢²á: 2011-11-10
- ÐÔ±ð: GG
- רҵ: Ïû»¯ÏµÍ³Ö×Áö
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
onewinder(½ð±Ò+1): »¶ÓÌṩ½¨Ò飬×îºÃÄÜ·Òë³ÉÖÐÎÄ 2011-11-12 02:54:05
onewinder(½ð±Ò+1): »¶ÓÌṩ½¨Ò飬×îºÃÄÜ·Òë³ÉÖÐÎÄ 2011-11-12 02:54:05
|
Patients received 50.4 Gy of radiation and concurrent bevacizumab (5 mg/kg on Days 1, 15, and 29), oxaliplatin (50 mg/m2/week for 6 weeks), and continuous infusion 5-FU (200 mg/m 2/day). Because of gastrointestinal toxicity, the ox- aliplatin dose was reduced to 40 mg/m2/week. Resection was performed 4 8 weeks after the completion of chemo-radiation ÎÄÕ±êÌ⣺NEOADJUVANT BEVACIZUMAB, OXALIPLATIN, 5-FLUOROURACIL, AND RADIATION FOR RECTAL CANCER Int. J. Radiation Oncology Biol. Phys., Vol. -, No. -, pp. 1¨C6, 2010 |
3Â¥2011-11-11 23:04:27
cancerguy
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 279
- Ìû×Ó: 22
- ÔÚÏß: 5Сʱ
- ³æºÅ: 1484906
- ×¢²á: 2011-11-10
- ÐÔ±ð: GG
- רҵ: Ïû»¯ÏµÍ³Ö×Áö
4Â¥2011-11-12 15:19:00
cancerguy
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 279
- Ìû×Ó: 22
- ÔÚÏß: 5Сʱ
- ³æºÅ: 1484906
- ×¢²á: 2011-11-10
- ÐÔ±ð: GG
- רҵ: Ïû»¯ÏµÍ³Ö×Áö
5Â¥2011-11-12 15:22:28













»Ø¸´´ËÂ¥